Faeth Therapeutics, Inc.: 10-Q filed 2022-08-09
What Faeth Therapeutics, Inc. reported in its quarterly report filed 2022-08-09 (fiscal Q2 2022): 32 published measures, 81 facts as tagged in accession 0000950170-22-016148.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2022-08-09
- Fiscal period
- fiscal Q2 2022
- Accession
- 0000950170-22-016148 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Faeth Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 138,036,000 | USD | |
| At 2021-12-31 | 153,225,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 12,120,000 | USD | |
| At 2021-12-31 | 6,712,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 125,916,000 | USD | |
| At 2022-03-31 | 135,308,000 | USD | |
| At 2021-12-31 | 146,513,000 | USD | |
| At 2021-06-30 | 163,125,000 | USD | |
| At 2021-03-31 | 171,252,000 | USD | |
| At 2020-12-31 | -56,443,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 9,899,000 | USD | |
| At 2021-12-31 | 7,159,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -10,535,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -22,940,000 | USD | 181 |
| 2022-01-01 to 2022-03-31 | -12,405,000 | USD | 90 |
| 2021-04-01 to 2021-06-30 | -9,771,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -17,743,000 | USD | 181 |
| 2021-01-01 to 2021-03-31 | -7,972,000 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | -22,649,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | -16,814,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 71,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | 1,103,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 164,065,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 25,389,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | -148,248,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | -172,146,000 | USD | |
| At 2021-12-31 | -149,206,000 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 0 | USD | 181 |
| 2021-01-01 to 2021-06-30 | 0 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 2,112,000 | USD | |
| At 2021-12-31 | 4,644,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 2,934,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | 3,095,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -10,712,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -23,199,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | -9,784,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -17,753,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 127,491,000 | USD | |
| At 2021-12-31 | 148,542,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 172,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 415,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 147,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 150,000 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 5,434,000 | USD | |
| At 2021-12-31 | 4,889,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 10,712,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 23,199,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 9,784,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 17,753,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 30,720,921 | shares | |
| At 2021-12-31 | 30,609,029 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | -1,212,000 | USD | |
| At 2021-12-31 | -333,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 5,971,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 6,161,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 3,602,000 | USD | |
| At 2021-12-31 | 5,833,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 1,490,000 | USD | |
| At 2021-12-31 | 1,189,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 45,000 | USD | |
| At 2021-12-31 | 39,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-12-31 | 149,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | -22,940,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | -17,743,000 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -10,848,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -23,819,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | -9,872,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -17,844,000 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -10,535,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -22,940,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | -9,771,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -17,743,000 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 4,319,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 9,351,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 3,886,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 8,490,000 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 144,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 301,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 122,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 220,000 | USD | 181 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 787,000 | USD | 181 |
Inspect the source
- Entity
- Faeth Therapeutics, Inc. / CIK 0001829802
- Captured
- 2026-09-21T17:30:11.338Z
- SEC response SHA-256
b1d736f6f07f638c86b6d14cb0a35613f04e3940985148e0eee4b52136236dc9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001829802.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))